These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2496589)

  • 1. Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in mice.
    Brouckaert PG; Everaerdt B; Libert C; Takahashi N; Fiers W
    Agents Actions; 1989 Jan; 26(1-2):196-8. PubMed ID: 2496589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor and interleukin-1 protection against the lethal effects of tumor necrosis factor.
    Sheppard BC; Norton JA
    Surgery; 1991 Jun; 109(6):698-705. PubMed ID: 2042087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.
    Bertini R; Bianchi M; Ghezzi P
    J Exp Med; 1988 May; 167(5):1708-12. PubMed ID: 3259257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor.
    Everaerdt B; Brouckaert P; Shaw A; Fiers W
    Biochem Biophys Res Commun; 1989 Aug; 163(1):378-85. PubMed ID: 2789044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.
    Waage A; Espevik T
    J Exp Med; 1988 Jun; 167(6):1987-92. PubMed ID: 3290384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
    Aggarwal BB; Eessalu TE
    J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
    Buscema M; Todd I; Deuss U; Hammond L; Mirakian R; Pujol-Borrell R; Bottazzo GF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tun T; Fukumoto M; Tobe T
    Biotherapy; 1991; 3(4):337-44. PubMed ID: 1786197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
    Havell EA; Fiers W; North RJ
    J Exp Med; 1988 Mar; 167(3):1067-85. PubMed ID: 3351434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1.
    Muchmore A; Decker J; Shaw A; Wingfield P
    Cancer Res; 1990 Oct; 50(19):6285-90. PubMed ID: 2400992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine regulation of interleukin 6 production by human endothelial cells.
    Shalaby MR; Waage A; Espevik T
    Cell Immunol; 1989 Jul; 121(2):372-82. PubMed ID: 2500254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    Dinarello CA; Cannon JG; Wolff SM; Bernheim HA; Beutler B; Cerami A; Figari IS; Palladino MA; O'Connor JV
    J Exp Med; 1986 Jun; 163(6):1433-50. PubMed ID: 3486936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.
    Brouckaert PG; Leroux-Roels GG; Guisez Y; Tavernier J; Fiers W
    Int J Cancer; 1986 Nov; 38(5):763-9. PubMed ID: 3095251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo.
    Shalaby MR; Waage A; Aarden L; Espevik T
    Clin Immunol Immunopathol; 1989 Dec; 53(3):488-98. PubMed ID: 2805453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo.
    Gatanaga T; Noguchi K; Tanabe Y; Inagawa H; Soma G; Mizuno D
    J Biol Response Mod; 1989 Jun; 8(3):278-86. PubMed ID: 2746298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T; Bendtzen K; Dinarello CA; Nerup J
    J Immunol; 1987 Dec; 139(12):4077-82. PubMed ID: 3320203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.